Rhythm Biosciences gains on Australian Genome Research Facility partnership

Rhythm Biosciences

29/01/2026 04:21

** Shares of Australia's Rhythm Biosciences RHY.AX rise as much as 16.7% to A$0.175, their highest level since January 16

    ** Medical diagnostics tech firm announces strategic partnership with Australian Genome Research Facility

** Partnership to establish commercial-scale processing capability for its predictive diagnostic tests platform, geneType, clinical services

** About 2.2 million shares traded so far, 2.6x the 30-day avg

** Stock up 22% in January so far, including the session's move

(Reporting by Anjali Singh in Bengaluru)

((anjali.singh2@thomsonreuters.com; ))